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occurs at codon 270 (Arg→Cys) involving a sequence
In order to assess the role played by the selectivity of change from 5Ј-TCGT to 5Ј-TTGT. We have shown previpyrimidine dimer formation in creating this distinct mutational ously that CPD formation by UVB or sunlight is enhanced hotspot, we have analyzed CPDs in mouse DNA along exon up to 10-fold at 5Ј-CCG and 5Ј-TCG sequences due to 8 of the p53 gene. Hairless female mice, 6-8 weeks old, were the presence of 5-methylcytosine bases. Sequence analysis obtained from Charles River Laboratories (strain SKH-1). showed that the CpG at codon 270 is methylated in mouse
Mice were irradiated in a cage in which they were able to epidermis at a level of~85%. Irradiation of mouse skin or move freely. The UVB source was a set of three Philips TL mouse cells in culture produced the strongest CPD signal 20W/12RS lamps (peak emission 320 nm) filtered through within exon 8 at the 5Ј-TCG sequence which is part of cellulose acetate. Lamps were positioned above the cage.
codon 270. Time course experiments showed that CPDs at
The UVB dose (~5000 J/m 2 ) was determined with a UVX this particular sequence persist longer than at several radiometer (Ultraviolet Products, Upland, CA) and corresponds neighboring positions. The data suggest that formation of to 16 min irradiation. After irradiation, mice were killed CPDs is responsible for induction of the major p53 mutaimmediately. The epidermis was isolated from dorsal skin by tional hotspot in UV-induced mouse skin tumors.
a trypsin flotation procedure (31) . The epidermis was minced with scissors and lysis buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM EDTA, 0.5% SDS, 100 µg/ml proteinase Skin cancer is the most common type of tumor in the USA K) was added. After incubation for 16 h at 37°C, DNA (1). Exposure to solar radiation is a principal factor in the was isolated by phenol/chloroform extraction and ethanol development of skin cancer (1, 2) . Human skin malignancies precipitation. The irradiation conditions introduced approxiand their precursor lesions commonly harbor mutations in the mately one CPD every 2.5 kb of DNA as determined by alkaline p53 tumor suppressor gene (3) (4) (5) (6) (7) (8) (9) (10) (11) . The predominant base agarose gel analysis (not shown). CPDs were mapped in the changes are C→T and CC→TT mutations at dipyrimidine p53 gene by ligation-mediated PCR (LMPCR). DNA isolation, sequences, two types of base alterations specifically induced enzymatic cleavage at CPDs and LMPCR were done as by UV light in many experimental systems (12) (13) (14) . Of the previously described (32) . The following primers, specific for various types of lesions formed in DNA after UV irradiation, exon 8 of the mouse p53 gene, were used in LMPCR: the cyclobutane pyrimidine dimer (CPD) is considered the primer 1, 5Ј-AGCTCAACAGGCTCCTCC; primer 2, 5Ј-GCmost mutagenic lesion based on its abundance, slow repair CTCCTTGGTCCCGCCTGC; primer 3, 5Ј-CCGCCTGCand distinct mutagenicity (15,16).
GTACCTCTCTTTGC. The LMPCR data were quantitated by In the p53 gene of human skin cancers~32% of all mutations phosphorimaging and by correcting for LMPCR amplification are C→T transition mutations within two unique trinucleotide efficiency at individual sites using the Maxam-Gilbert TϩC sequences, 5Ј-TCG and 5Ј-CCG. 5Ј-CG (CpG) sequences in lanes as a reference. The numbers obtained are the relative the human p53 gene are methylated to form 5Ј-mCG (17) .
CPD frequencies along a particular sequence. Thus, many skin cancer mutations may involve formation of Figure 2 shows an analysis of the upper strand of exon 8 pyrimidine dimers containing 5-methylcytosine bases. It was where the common C→T transition at codon 270 occurs. shown previously that CPD formation by sunlight or UVB is
The strongest CPD signal along the entire exon is seen at enhanced up to 10-fold at 5Ј-CCG and 5Ј-TCG sequences codon 270. Relative CPD frequencies are shown in Table I . relative to UVC (254 nm) irradiation due to the presence of Mouse codon 270 corresponds to human p53 codon 273. 5-methylcytosine (18,19). In the CpG-methylated lacI transMutations at codon 273 are rare in human skin cancers, gene, sunlight, but not UVC irradiation, produces mutational presumably because it is not part of a dipyrimidine sequence (5Ј-G-CGT-G). However, codon 273 is a prominent hotspot of Abbreviations: CPD, cyclobutane pyrimidine dimer; LMPCR, ligationmediated polymerase chain reaction.
mutation in many other tumors. This could be a consequence of preferred targeting by mutational events at methylated CpG sequences (33) (34) (35) and/or tumorigenic selection. It is unlikely that mutations at codon 270 are produced by (6-4) photoproducts, since these form at very low levels and are suppressed at positions of 5-methylcytosines (16).
CPDs also form at codon 275, which is the second most common mutation site in mouse skin cancers (Figure 1 ), but they are much less pronounced than at codon 270. Mouse codon 275, which lacks a CpG sequence, corresponds to human codon 278. Interestingly, codon 278 is also a mutational hotspot in human skin cancer, similarly involving dipyrimidine transitions at a non-CpG sequence. Only moderate levels of CPDs are observed in human (36) and mouse p53 ( Figure 2 and Table I ) at these sequences. One possibility is that mutation at codon 275/278 is particularly tumorigenic in skin. Although considered less likely, the major mutagenic lesion at codon 275/278 may be the (6-4) photoproduct (37) or even a minor DNA photoproduct.
Significant levels of CPDs are seen at codons 261/262. Mutations in UVB-induced mouse skin tumors are relatively rare at these codons (Figure 1) . A C→T change at codon 262 would be silent (Leu→Leu), but a C→T mutation at 261 would produce a Leu→Phe change. This amino acid substitution may not be highly tumorigenic. Changes at the analogous human codon 264 are rare in the p53 database of Ͼ11 000 entries (38) . In fact, almost all mutations at this position in the human p53 gene are frameshifts. Furthermore, although TT dimers are formed at high levels at several sites (Table I) , they are thought to be only weakly mutagenic in eukaryotic cells (39-41).
The preferential formation of CPDs at codon 270 may be product encompassing exon 8 of the mouse p53 gene was either mock-methylated or was methylated in vitro with the CpG-specific DNA methyltransferase MSssI. Methylated and as standards and comparing the CpG cytosine signal to the intensities of neighboring cytosines at non-CpG sequences, we unmethylated PCR products were then chemically sequenced. The presence of 5-methylcytosine is indicated by lack of a calculate that the extent of methylation at codon 270 was 85% in mouse epidermis and 98% in embryonic fibroblasts (Figure band due to lack of reactivity with hydrazine in the sequencing gels (Figure 3, lanes 5 and 6) . Using the two control DNAs 3). CpG sequences at codons 279, 280 and 287 were also Ͼ80% methylated in skin (data not shown). The preferential targeting of a dipyrimidine within a methylated CpG sequence context is consistent with earlier data showing that methylation of cytosines dramatically enhances formation of CPDs in the UVB range (18,19). An additional possible pathway that may target UV mutagenesis to dipyrimidines containing 5-methylcytosine is that most UV-induced transition mutations at these sequences may result from correct DNA polymerase bypass of CPDs containing deaminated 5-methylcytosine (42). We next measured repair rates for CPDs along exon 8 of the p53 gene. Mouse embryonic fibroblasts (derived from C57BL/6 λLIZ transgenic mice; Stratagene) were irradiated with UVB as confluent monolayers (to prevent dilution of the LMPCR signal by cell division). The medium was removed and cells were washed in phosphate-buffered saline and irradiated for 80 s with the UVB light source (400 J/m 2 ). Then the medium was returned and the cells were incubated for periods of up to 48 h. Repair efficiency at individual CPD positions was calculated after densitometry of the LMPCR gels. The time course of CPD removal was monitored for up to 48 h. Most CPDs were at least partially removed after 48 h (Figure 4 ). At the 48 h time point there was a site-to-site difference in repair efficiency. The data were quantitated and are included in Table I . Codon 270 is a site at which repair of CPDs was less after 48 h compared with neighboring CPD positions. However, as can be seen for codons 278-280, it was not the only site at which significant levels of CPDs heterogeneity. Cancer Res., 53, 2961-2964. 22. van Kranen,H.J., de Gruijl,F.R., de Vries,A., Sontag,Y., Wester,P.W.,
